把三张表、经营指标、SEC / 巨潮 / 港交所原始财报、业绩材料和电话会放到同一条可核验时间线上。 披露事实、结构化补位值与派生指标分开标注,缺失逐字稿不会用摘要或模型生成内容补齐。
单季、累计、年度和资产负债表时点分开保存;每个数值都保留单位、申报日、表单、XBRL 概念或原始中文字段。
美股链接 SEC 法定申报和发行人 IR,A 股链接巨潮原始 PDF,港股链接港交所披露易原始年报与中报。分部、订单、产能和客户集中度只在有可核验披露时展示。
官方电话会入口与已授权逐字稿分开。没有合法取得的全文时只显示材料可用性,不生成或拼接虚假的逐字稿。
三张表会执行资产负债、毛利润、税前利润等勾稽检查;超出容差的记录保留原值并标记警告, 不会为了让公式“对上”而修改公司披露。
| 2026-05-23 |
| 3/3 |
| $46.12B |
| $903M |
| — |
| — |
| 3.1% |
| 99 |
| 尚无授权文本 |
| ASPN ASPEN AEROGELS INC | 2026-03-31 | 3/3 | $37.88M | -$23.69M | $32.78M | 11.3% | -55.0% | 106 | 尚无授权文本 |
| BFRG BullFrog AI Holdings, Inc. | 2026-03-31 | 3/3 | — | -$1.59M | — | — | — | 61 | 尚无授权文本 |
| FROG JFrog Ltd | 2026-03-31 | 3/3 | $153.98M | -$8.27M | $37.29M | 78.2% | -8.4% | 65 | 尚无授权文本 |
| LFAC Leapfrog Acquisition Corp | 2026-03-31 | 3/3 | — | $1.07M | — | — | — | 6 | 尚无授权文本 |
| LFACU Leapfrog Acquisition Corp | 2026-03-31 | 3/3 | — | $1.07M | — | — | — | 6 | 尚无授权文本 |
| MGNX MACROGENICS INC | 2026-03-31 | 3/3 | $20.78M | -$36.77M | -$36.16M | — | -161.0% | 96 | 尚无授权文本 |
| NGNE Neurogene Inc. | 2026-03-31 | 3/3 | — | -$30.93M | -$26.4M | — | — | 100 | 尚无授权文本 |
| PGNY Progyny, Inc. | 2026-03-31 | 3/3 | $328.5M | $24.23M | $39.6M | 25.3% | 10.8% | 73 | 尚无授权文本 |
| PGR PROGRESSIVE CORP/OH/ | 2026-03-31 | 3/3 | $22.19B | $2.82B | $4.3B | — | — | 81 | 尚无授权文本 |
| ROG ROGERS CORP | 2026-03-31 | 3/3 | $200.5M | $4.5M | $1.1M | 32.2% | 5.3% | 91 | 尚无授权文本 |
| SERA SERA PROGNOSTICS, INC. | 2026-03-31 | 3/3 | $14,000 | -$8.4M | -$8.78M | -200.0% | -66857.1% | 70 | 尚无授权文本 |
| URGN UroGen Pharma Ltd. | 2026-03-31 | 3/3 | $50.96M | -$23.57M | -$45.37M | 91.9% | -39.8% | 87 | 尚无授权文本 |
| GSM Ferroglobe PLC | 2025-12-31 | 2/3 | — | -$177.11M | — | — | — | 95 | 尚无授权文本 |
| RCI ROGERS COMMUNICATIONS INC | 2025-12-31 | 2/3 | — | $6.91B | — | — | — | 201 | 尚无授权文本 |